Status:

COMPLETED

Gastric Emptying - Implications for the Pathogenesis of Type 2 Diabetes

Lead Sponsor:

University of Nottingham

Collaborating Sponsors:

University of Adelaide

Conditions:

Diabetes Mellitus, Type 2

Eligibility:

All Genders

18-60 years

Brief Summary

People of black African and Caribbean descent have a greater risk of developing type 2 diabetes than white Europeans. The aim of this study is to increase our knowledge of how the condition may arise,...

Detailed Description

Background It is recognized that there are differences between ethnic groups in the risk of developing type 2 diabetes (T2D), but the underlying pathophysiology remains poorly defined. For example, wh...

Eligibility Criteria

Inclusion

  • White European or black African / Caribbean heritage
  • BMI \>18 kg/m2
  • Ability to give written informed consent
  • English speaking

Exclusion

  • Any significant medical condition
  • Uncontrolled hypertension
  • Alcohol consumption \>14 units / week
  • Random blood Glucose concentration above 7.8mmol/l
  • Hemoglobin A1c (HbA1c) \>47mmol/mol (\>6.4%)
  • Use of regular medication, (oral contraceptive pill or antihypertensive medication are acceptable if use has been for \>6 months)
  • History of Irritable Bowel Syndrome, food intolerances or any gastrointestinal disorders
  • Previous bariatric surgery, or gastrointestinal surgery which may affect normal function (e.g. bowel resection)

Key Trial Info

Start Date :

March 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 31 2023

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT03864562

Start Date

March 1 2019

End Date

March 31 2023

Last Update

December 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

David Greenfield Human Physiology Unit, University of Nottingham

Nottingham, Notts, United Kingdom, NG72UH